Anacetrapib (MK-0859)
目录号: A11084
CETP 抑制剂
Anacetrapib (MK-0859) 是一种正在开发中的 CETP 抑制剂,用于治疗高胆固醇血症(胆固醇水平升高)并预防心血管疾病。
Discription | Anacetrapib (MK-0859) is a CETP inhibitor being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease. | |||||
---|---|---|---|---|---|---|
Cell Research |
|
目录号 | A11084 |
---|---|
分子式 | C30H25F10NO3 |
分子量 | 637.5 |
CAS号 | 875446-37-0 |
SMILES | C[C@H]1[C@H](OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F |
其他名称 | MK0859 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 108 mg/mL (169.41 mM) | |
Water | Insoluble | ||
Ethanol | 108 mg/mL (169.41 mM) | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 15.69 mL | 78.43 mL | 156.86 mL |
0.5 mM | 3.14 mL | 15.69 mL | 31.37 mL |
1 mM | 1.57 mL | 7.84 mL | 15.69 mL |
5 mM | 0.31 mL | 1.57 mL | 3.14 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2